• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经典半乳糖血症长期并发症的病理生理学:我们所知与未知。

Pathophysiology of long-term complications in classic galactosemia: What we do and do not know.

机构信息

Department of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322, USA.

Division of Genetics and Genomics, Department of Pediatrics, Boston Children's Hospital and Harvard Medical School, Boston, MA 02115, USA.

出版信息

Mol Genet Metab. 2022 Sep-Oct;137(1-2):33-39. doi: 10.1016/j.ymgme.2022.07.005. Epub 2022 Jul 9.

DOI:10.1016/j.ymgme.2022.07.005
PMID:35882174
Abstract

Despite many decades of research involving both human subjects and model systems, the underlying pathophysiology of long-term complications in classic galactosemia (CG) remains poorly understood. In this review, intended for those already familiar with galactosemia, we focus on the big questions relating to outcomes, mechanism, and markers, drawing on relevant literature where available, attempting to navigate inconsistencies where they appear, and acknowledging gaps in knowledge where they persist.

摘要

尽管在经典半乳糖血症(CG)的研究中涉及到人类受试者和模型系统已经有几十年了,但长期并发症的潜在病理生理学仍然知之甚少。在这篇综述中,我们针对已经熟悉半乳糖血症的读者,重点关注与结局、机制和标志物相关的大问题,在可能的情况下参考相关文献,尝试在出现不一致的地方进行导航,并承认在知识的空白仍然存在的地方。

相似文献

1
Pathophysiology of long-term complications in classic galactosemia: What we do and do not know.经典半乳糖血症长期并发症的病理生理学:我们所知与未知。
Mol Genet Metab. 2022 Sep-Oct;137(1-2):33-39. doi: 10.1016/j.ymgme.2022.07.005. Epub 2022 Jul 9.
2
Transient developmental delays in infants with Duarte-2 variant galactosemia.患有 2 型达尔特变异半乳糖血症婴儿的短暂性发育迟缓。
Mol Genet Metab. 2021 Sep-Oct;134(1-2):132-138. doi: 10.1016/j.ymgme.2021.07.009. Epub 2021 Jul 30.
3
The molecular biology of galactosemia.半乳糖血症的分子生物学
Genet Med. 1998 Nov-Dec;1(1):40-8. doi: 10.1097/00125817-199811000-00009.
4
Galactosemia: when is it a newborn screening emergency?半乳糖血症:何时属于新生儿筛查急症?
Mol Genet Metab. 2012 May;106(1):7-11. doi: 10.1016/j.ymgme.2012.03.007. Epub 2012 Mar 21.
5
A galactose-1-phosphate uridylyltransferase-null rat model of classic galactosemia mimics relevant patient outcomes and reveals tissue-specific and longitudinal differences in galactose metabolism.经典半乳糖血症的半乳糖-1-磷酸尿苷酰转移酶缺失大鼠模型模拟了相关的患者结局,并揭示了半乳糖代谢在组织特异性和纵向方面的差异。
J Inherit Metab Dis. 2020 May;43(3):518-528. doi: 10.1002/jimd.12205. Epub 2019 Dec 29.
6
Effect of genotype on galactose-1-phosphate in classic galactosemia patients.经典型半乳糖血症患者基因型对 1-磷酸半乳糖的影响。
Mol Genet Metab. 2018 Nov;125(3):258-265. doi: 10.1016/j.ymgme.2018.08.012. Epub 2018 Aug 23.
7
A Drosophila melanogaster model of classic galactosemia.黑腹果蝇经典半乳糖血症模型。
Dis Model Mech. 2010 Sep-Oct;3(9-10):618-27. doi: 10.1242/dmm.005041. Epub 2010 Jun 2.
8
Oxidative stress contributes to outcome severity in a Drosophila melanogaster model of classic galactosemia.氧化应激导致经典半乳糖血症果蝇模型中结局严重程度的增加。
Dis Model Mech. 2013 Jan;6(1):84-94. doi: 10.1242/dmm.010207. Epub 2012 Jul 5.
9
[From gene to disease; galactosemia and galactose-1-phosphate uridyltransferase deficiency].[从基因到疾病;半乳糖血症与1-磷酸半乳糖尿苷转移酶缺乏症]
Ned Tijdschr Geneeskd. 2004 Jan 10;148(2):80-1.
10
Pathophysiology and targets for treatment in hereditary galactosemia: A systematic review of animal and cellular models.遗传性半乳糖血症的病理生理学和治疗靶点:动物和细胞模型的系统评价。
J Inherit Metab Dis. 2020 May;43(3):392-408. doi: 10.1002/jimd.12202. Epub 2020 Jan 14.

引用本文的文献

1
Clinical and Developmental Outcomes After 50 Years of Newborn Bloodspot Screening for Classical Galactosaemia in the Republic of Ireland.爱尔兰共和国对典型半乳糖血症进行新生儿血斑筛查50年后的临床和发育结局
JIMD Rep. 2025 May 26;66(3):e70022. doi: 10.1002/jmd2.70022. eCollection 2025 May.
2
Patterns of Penetrance and Expressivity of Long-Term Outcomes in Classic Galactosemia.经典型半乳糖血症长期预后的外显率和表现度模式
J Inherit Metab Dis. 2025 May;48(3):e70020. doi: 10.1002/jimd.70020.
3
Single-nucleus and spatial transcriptomics of paediatric ovary: Molecular insights into the dysregulated signalling pathways underlying premature ovarian insufficiency in classic galactosemia.
儿科卵巢的单细胞和空间转录组学:经典半乳糖血症中卵巢功能不全失调信号通路的分子研究。
Clin Transl Med. 2024 Oct;14(10):e70043. doi: 10.1002/ctm2.70043.
4
Motor Milestones: Sensory Motor Trends of Young Children with Classic Galactosemia.运动发育里程碑:经典型半乳糖血症幼儿的感觉运动趋势
J Occup Ther Sch Early Interv. 2024;17(2):216-227. doi: 10.1080/19411243.2023.2192206. Epub 2023 Mar 27.
5
Galactokinase 1 is the source of elevated galactose-1-phosphate and cerebrosides are modestly reduced in a mouse model of classic galactosemia.在经典半乳糖血症小鼠模型中,半乳糖激酶1是导致1-磷酸半乳糖升高的原因,脑苷脂也略有减少。
JIMD Rep. 2024 Jun 23;65(4):280-294. doi: 10.1002/jmd2.12438. eCollection 2024 Jul.
6
Restoring galactose metabolism without restoring GALT rescues both compromised survival in larvae and an adult climbing deficit in a GALT-null D. Melanogaster model of classic galactosemia.在缺乏 GALT 的情况下,恢复半乳糖代谢而不恢复 GALT,可挽救经典半乳糖血症的 GALT 缺失 D. melanogaster 模型中幼虫的生存能力受损和成年后攀爬能力缺陷。
J Inherit Metab Dis. 2024 Sep;47(5):991-1000. doi: 10.1002/jimd.12774. Epub 2024 Jul 3.
7
Clinical and biochemical phenotypes, genotypes, and long-term outcomes of individuals with galactosemia type I from a single metabolic genetics center in Alberta.来自艾伯塔省一个代谢遗传学中心的I型半乳糖血症患者的临床和生化表型、基因型及长期预后
Mol Genet Metab Rep. 2024 Jan 25;38:101055. doi: 10.1016/j.ymgmr.2024.101055. eCollection 2024 Mar.
8
Neuropsychological stability in classical galactosemia: A pilot study in 10 adult patients.经典型半乳糖血症患者的神经心理稳定性:10例成年患者的初步研究
JIMD Rep. 2024 Jan 9;65(2):110-115. doi: 10.1002/jmd2.12410. eCollection 2024 Mar.
9
Long-term complications in classic galactosemia are not progressive.经典半乳糖血症的长期并发症并非进行性的。
Mol Genet Metab. 2023 Nov;140(3):107708. doi: 10.1016/j.ymgme.2023.107708. Epub 2023 Oct 11.
10
Understanding the patient experience of Classic Galactosemia in pediatric and adult patients: increased disease burden, challenges with daily living, and how they evolve over time.了解 Classic Galactosemia 患儿和成年患者的体验:疾病负担增加、日常生活挑战以及随时间推移的变化。
J Patient Rep Outcomes. 2023 Sep 26;7(1):95. doi: 10.1186/s41687-023-00635-2.